All Stories

  1. Transforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model
  2. Testosterone and the Prostate
  3. Phosphodiesterase type 5 inhibitors for stuttering priapism: recent advances
  4. Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility
  5. Update on Medical Management of Peyronie’s Disease
  6. Clinical Use of Aromatase Inhibitors in Adult Males
  7. PD22-06 EFFICACY OF PENILE TRACTION THERAPY AMONG PATIENTS UNDERGOING INTRALESIONAL INTERFERON TREATMENT FOR PEYRONIE’S DISEASE
  8. PD22-02 MEANINGFUL CHANGE IN PEYRONIE’S DISEASE FOLLOWING TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM: RESULTS FROM TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES
  9. MP47-14 PIOGLITAZONE IS PROTECTIVE AGAINST POST-PROSTATECTOMY ERECTILE DYSFUNCTION
  10. V8-04 INTRA-CORPOREAL ROBOTIC ASSISTED VASO-VASOSTOMY FOR THE MANAGEMENT OF BILATERAL VASSAL OBSTRUCTION FOLLOWING INGUINAL HERNIORRHAPHY WITH MESH
  11. MP13-16 A TGF-β1 BASED RAT MODEL FOR URETHRAL STRICTURE
  12. The Non-Surgical Treatment of Peyronie Disease: 2013 Update
  13. Life threatening intraperitoneal hemorrhage with abdominal compartment syndrome: Unusual presentation of renal angiomyolipoma